Page last updated: 2024-08-21

arsenic trioxide and cetyltrimethylammonium ion

arsenic trioxide has been researched along with cetyltrimethylammonium ion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, XJ; Fan, XD; Li, FZ; Piao, JG; Wang, BH; Wei, YH; Zhang, BB; Zheng, HS; Zheng, HY; Zhu, JJ	1

Other Studies

1 other study(ies) available for arsenic trioxide and cetyltrimethylammonium ion

Article	Year
Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells. Acta pharmacologica Sinica, 2021, Volume: 42, Issue:5 Topics: Acrylic Resins; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Breast Neoplasms; Cell Proliferation; Cetrimonium; Drug Carriers; Drug Liberation; Female; G2 Phase Cell Cycle Checkpoints; Human Umbilical Vein Endothelial Cells; Humans; MCF-7 Cells; Mice, Inbred ICR; Nanoparticles; Oligopeptides; Paclitaxel; Porosity; Silicon Dioxide; Xenograft Model Antitumor Assays	2021

Article

Year

Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.

Acta pharmacologica Sinica, 2021, Volume: 42, Issue:5

Topics: Acrylic Resins; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Breast Neoplasms; Cell Proliferation; Cetrimonium; Drug Carriers; Drug Liberation; Female; G2 Phase Cell Cycle Checkpoints; Human Umbilical Vein Endothelial Cells; Humans; MCF-7 Cells; Mice, Inbred ICR; Nanoparticles; Oligopeptides; Paclitaxel; Porosity; Silicon Dioxide; Xenograft Model Antitumor Assays

2021